Organisatie
Verwaarloosde Tropische Ziekten
Research Unit
Projecten
1 - 10 of 51
- An economic evaluation of strategies for sleeping sickness eliminationVanaf3 jul 2019 → Heden
- Community Participation in Neglected Tropical Diseases Elimination: A case study of Human African Trypanosomiasis elimination in Democratic Republic of CongoVanaf3 jul 2019 → Heden
- The role of innovative tools for sand fly control in the visceral leishmaniasis (VL) elimination initiative in the South-East-Asian regionVanaf11 apr 2019 → Heden
- Cryptic human and animal reservoirs compromise the sustainedelimination of gambiense-human African trypanosomiasis in the Democratic Republic of the CongoVanaf1 dec 2018 → 30 nov 2023
- Azithromycin and opportunities for integrated control of Neglected Tropical DiseasesVanaf1 nov 2018 → 31 jan 2020
- A systemic insecticide to control zoonotic cutaneous leishmaniasis in Errachidia province - Southeastern Morocco: an intervention trial for an innovative vector control toolVanaf1 nov 2018 → 31 dec 2023
- Post exposure prophylaxis for leprosy in the Comoros and MadagascarVanaf1 sep 2018 → 28 feb 2023
- Innovative strategies to ascertain the Elimination of Visceral Leishmaniasis in NepalVanaf11 jul 2018 → Heden
- Non-commercial clinical research in neglected tropical diseasesVanaf11 jul 2018 → 31 dec 2020
- To strengthen Institute of Tropical Medicine Pedro Kouri (IPK, Cuba) and National Institute of Hygiene, Epidemiology and Microbiology (INHEM, Cuba) towards accomplishment of their academic mission through capacity building and scientific co-operation.Vanaf1 jan 2018 → 31 dec 2018
Publicaties
431 - 440 van 442
- Should I get screened for sleeping sickness? A qualitative study in Kasai Province, Democratic Republic of Congo(2012)
Auteurs: A Mpanya, David Hendrickx, M. Vuna, A Kanyinda, C Lumbala, V Tshilombo, P Mitashi, O Luboya, V Kande, Marleen Boelaert, et al.
Pagina's: e1467 - Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease(2014)
Auteurs: Marleen Boelaert, K Verdonck, Joris Menten, Temmy Sunyoto, Johan van Griensven, Francois Chappuis, Suman Rijal
Pagina's: CD009135 - Onchocerciasis prevalence among persons with epilepsy in an onchocerciasis hypo-endemic area in the Democratic Republic of Congo: a cross-sectional study(2021)
Auteurs: An Hotterbeekx, K Verdonck, Deby Mukendi, Jean Roger Kalo Lilo, Pascal Lutumba, Marleen Boelaert, Liselotte Hardy, Barbara Barbé, Jan Jacobs, Emmanuel Bottieau, et al.
- A pseudo-outbreak of pre-XDR TB in Kinshasa(2014)
Auteurs: Michel Kaswa Kayomo, Muriel Aloni, Léontine Nkuku, Brian Bakoko, Rossin Lebeke, Albert Nzita, Jean-Jacques Muyembe, Bouke de Jong, Pim De Rijk, Jan Verhaegen, et al.
Pagina's: 2876-2880 - The COVID-19 pandemic: diverse contexts; different epidemics-how and why?(2020)
Auteurs: Wim Van Damme, Ritwik Dahake, Alexandre Delamou, Edwin Wouters, Guido Vanham, Remco van de Pas, Jean-Paul Dossou, Por Ir, Seye Abimbola, Stefaan Van der Borght, et al.
- Intestinal helminthiasis as a determinant of response to pentavalent antimony treatment in Peruvian patients with cutaneous leishmaniasis: a case-control study(2017)
Auteurs: D. Y. Martinez, K Verdonck, V. Adaui, M. Jara, M. Alba, J Arevalo, Katja Polman, A Llanos-Cuentas, Jean-Claude Dujardin, Marleen Boelaert
Pagina's: 43-44 - Efficacy of miltefosine in the treatment of visceral leishmaniasis after a decade of use in India(2012)
Auteurs: Shyam Sundar, A. Singh, M. Rai, V.K. Prajapati, A.K. Singh, Bart Ostyn, Marleen Boelaert, Jean-Claude Dujardin, J Chakravarty
Pagina's: 543-550 - Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India(2013)
Auteurs: P Srivastava, K. Gidwani, A Picado, G Van der Auwera, P. Tiwary, Bart Ostyn, Jean-Claude Dujardin, Marleen Boelaert, Shyam Sundar
Pagina's: 548-554 - Reply to Dr. Sushmita Das(2013)
Auteurs: Jean-Claude Dujardin, N.R. Bhattarai, Keshav Rai, M Vanaerschot, Surendra Uranw, Bart Ostyn, Marleen Boelaert, Suman Rijal
Pagina's: 1365-1366 - Visceral leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal leishmaniasis(2018)
Auteurs: Tegwen Marlais, Tapan Bhattacharyya, Om Prakash Singh, Pascal Mertens, Quentin Gilleman, Caroline Thunissen, Bruno C Bremer Hinckel, Callum Pearson, Bathsheba L. Gardner, Stephanie Airs, et al.